0000899243-18-001522.txt : 20180119 0000899243-18-001522.hdr.sgml : 20180119 20180119162544 ACCESSION NUMBER: 0000899243-18-001522 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180117 FILED AS OF DATE: 20180119 DATE AS OF CHANGE: 20180119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ceesay Abraham CENTRAL INDEX KEY: 0001722140 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38293 FILM NUMBER: 18537592 MAIL ADDRESS: STREET 1: C/O SCPHARMACEUTICALS, INC. STREET 2: 2400 DISTRICT AVENUE SUITE 310 CITY: BURLINGTON STATE: MA ZIP: 01830 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: scPharmaceuticals Inc. CENTRAL INDEX KEY: 0001604950 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465184075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2400 DISTRICT AVENUE STREET 2: SUITE 310 CITY: BURLINGTON STATE: MA ZIP: 01830 BUSINESS PHONE: 617-517-0730 MAIL ADDRESS: STREET 1: 2400 DISTRICT AVENUE STREET 2: SUITE 310 CITY: BURLINGTON STATE: MA ZIP: 01830 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-17 0 0001604950 scPharmaceuticals Inc. SCPH 0001722140 Ceesay Abraham C/O SCPHARMACEUTICALS INC. 2400 DISTRICT AVENUE, SUITE 310 BURLINGTON MA 01830 0 1 0 0 Chief Operating Officer Stock Option (Right to Buy) 12.23 2018-01-17 4 A 0 80971 0.00 A 2028-01-17 Common Stock 80971 80971 D The option shares vest over a four-year period, at a rate of 25% on the first anniversary of the grant date, with the remaining option shares vesting in 36 equal monthly installments thereafter, such that the option shares are fully vested on the fourth anniversary of the grant date. /s/ Courtney Gaughan, attorney in fact 2018-01-19